Skip to main content
. 2021 Feb 27;12:2040622320983121. doi: 10.1177/2040622320983121

Figure 3.

Figure 3.

(a) DMTs’ distribution among the three groups; (b) DMTs’ line distribution among the three groups.

DMT, disease-modifying therapy; RRMS, relapsing–remitting multiple sclerosis.